JPRN-jRCT2080221595未知2 期
A Randomized Phase II study of S-1 and LV versus S-1, LV and L-OHP versus S-1 and CDDP in Patients with Advanced Gastric Cancer
适应症
试验速览
- 阶段
- 2 期
- 入组人数
- 144
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Patients must be diagnosed as advanced gastric cancer
- •- Age: 20 years or order
- •- Eastern Cooperative Oncology Group (ECOG) performance status (PS) of 0 or 1
- •- Sufficient oral intake
- •- Written informed consent
- •- At least one measurable lesion by RECIST criteria
排除标准
- •- Diarrhea
- •- History or presence of severe pulmonary disease
- •- History or presence of severe heart disease
- •- Uncontrolled or severe diabetes
- •- Severe complications(e.g., severe enteritis, severe stomatitis, gastrointestinal ulcer)
研究者
相似试验
未知
2 期
Phase II Study of S-1 plus LV (1 week on and 1 week off) as First-line Treatment for Patients with metastatic colorectal cancer.Colorectal CancerJPRN-jRCT2080220727Taiho Pharmaceutical Co., Ltd.
未知
2 期
A Randomized Phase II Study of S-1 plus Leucovorin versus S-1 alone in Patients with Gemcitabine-Refractory Advanced Pancreatic Cancer.Pancreatic cancerJPRN-jRCT2080221515Taiho Pharmaceutical Co., Ltd.140
已完成
2 期
A Multicenter phase II study of S-1 combined with bevacizumab after platinum-based chemotherapy in patients with advanved non-squamous non-small cell lung cancerJPRN-UMIN000007386Division of Respirology, Neurology, and Rheumatology, Department of Internal Medicine, Kurume University School of Medicine28
已完成
2 期
Randomized phase II study comparing S-1 plus oxaliplatin with S-1 monotherapy for elderly patients with advanced gastric cancer.(WJOG8315G)advanced gastric cancer.JPRN-UMIN000020864West Japan Oncology Group160
进行中（未招募）
2 期
Randomized phase II study comparing S-1 plus oxaliplatin with S-1 monotherapy for elderly patients with advanced gastric cancer.(WJOG8315G)Advanced gastric cancer.JPRN-jRCTs041190004Makiyama Akitaka160